Skip to main content
SpringerLink
Log in

Incidence and pathophysiology of hypercalcemia

  • Symposium Proceedings
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Hypercalcemia occurs for various reasons in patients with malignant diseases. Most of these patients show a relative increase in bone resorption over bone formation. Increased renal tubular calcium reabsorption is also important for maintaining hypercalcemia in the majority of patients. Calcium absorption from the gut is usually decreased. In a few patients, fixed impairment of glomerular filtration contributes to hypercalcemia. Because the pathophysiology of hypercalcemia is heterogeneous, it may be considered as three separate syndromes: the humoral hypercalcemia of malignancy caused by systemic mediators; the hypercalcemia associated with localized osteolytic disease; and the hypercalcemia associated with myeloma and related hematologic malignancies. Increased bone resorption is a key feature in each of these syndromes. In malignant disease, bone resorption is enhanced because osteoclast activity is increased by the production of humoral mediators. These mediators are often produced by the tumor cells but are also produced by normal host cells that have been activated by the presence of the tumor. Some of these mediators of hypercalcemia are systemic factors, but some act only locally. They include parathyroid hormone-related protein, transforming growth factor alpha, lymphotoxin, tumor necrosis factor, interleukin-1 alpha and 1,25-dihydroxyvitamin D.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mundy GR, Cove DH, Fisken R: Primary hyperparathyroidism: changes in the pattern of clinical presentation.Lancet 1980;i:1317–1320

    Article  Google Scholar 

  2. Health III H, Hodgson SF, Kennedy MA: Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community.N Engl J Med 1980;301:189–193

    Article  Google Scholar 

  3. Mundy GR, Martin TJ: The hypercalcemia of malignancy: pathogenesis and management.Metabolism 1982;31:1247–1277

    Article  PubMed  CAS  Google Scholar 

  4. Mundy GR: Calcium homeostasis: hypercalcemia and hypocalcemia. M. Dunitz, 1989

  5. Peacock M, Robertson WG, Nordin BEC: Relation between serum and urine calcium with particular reference to parathyroid activity.Lancet 1969;i:384–386

    Article  Google Scholar 

  6. Albright F: Case records of the Massachusetts General Hospital—case 39061.N Engl J Med 1941;225:789–796

    Article  Google Scholar 

  7. Lafferty FW: Pseudohyperparathyroidism. Medicine [Baltimore] 1966;45:247–260

    Article  PubMed  CAS  Google Scholar 

  8. Stewart AF, Horst R, Deftos LJ,et al: Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.N Engl J Med 1980;303:1377–1383

    Article  PubMed  CAS  Google Scholar 

  9. Goltzman D, Stewart AF, Broadus AE: Malignancy-associated hypercalcemia: evaluation with a cytochemical bioassay for parathyroid hormone.J Clin Endocrinol Metab 1981; 53:899–904

    PubMed  CAS  Google Scholar 

  10. Moseley JM, Kubota M, Diefenbach-Jagger H,et al: Parathyroid hormone-related protein purified from a human lung cancer cell line.Proc Natl Acad Sci USA 1987;84:5048–5052

    Article  PubMed  CAS  Google Scholar 

  11. Stewart AF, Wu T, Goumas D,et al: N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains.Biochem Biophys Res Commun 1987;146:672–678

    Article  PubMed  CAS  Google Scholar 

  12. Strewler GJ, Stern PH, Jacobs JW,et al: Parathyroid hormone-like protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone.J Clin Invest 1987;80:1803–1807

    PubMed  CAS  Google Scholar 

  13. Suva LJ, Winslow GA, Wettenhall REH,et al: A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression.Science 1987;237:893–896

    Article  PubMed  CAS  Google Scholar 

  14. Mangin M, Wegg AC, Dreyer BE,et al: Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.Proc Natl Acad Sci USA 1988;85:597–601

    Article  PubMed  CAS  Google Scholar 

  15. Kemp BE, Moseley JM, Rodda CP,et al: Parathyroid hormone-related protein of malignancy: active synthetic fragments.Science 1987;238:1568–1570

    Article  PubMed  CAS  Google Scholar 

  16. Horiuchi N, Caulfield MP, Fisher JE,et al: Similarity of synthetic peptide from human tumor to parathyroid hormonein vivo andin vitro.Science 1987;238:1566–1567

    Article  PubMed  CAS  Google Scholar 

  17. Stewart AF, Mangin M, Wu T,et al: Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.J Clin Invest 1988;81:596–600

    PubMed  CAS  Google Scholar 

  18. Yates AJP, Gutierrez GE, Smolens P,et al: Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tumor calcium reabsorption and bone metabolism.J Clin Invest 1988;81:932–938

    PubMed  CAS  Google Scholar 

  19. Todaro GJ, Fryling D, DeLarco JE; Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.Proc Natl Acad Sci USA 1980;77:5258–5262

    Article  PubMed  CAS  Google Scholar 

  20. Ibbotson KJ, Twardzik DR, D'Souza SM,et al: Stimulation of bone resorptionin vitro by synthetic transforming growth factor-alpha.Science 1985;228:1007–1009

    Article  PubMed  CAS  Google Scholar 

  21. Ibbotson KJ, Harrod J, Gowen M,et al: Effects of human transforming growth factor (TGF) alpha on bone resorption and formationin vitro.Proc Natl Acad Sci USA 1986;83: 2228–2232

    Article  PubMed  CAS  Google Scholar 

  22. Tashjian AH, Voelkel EF, Lazzaro M,et al: Alpha and beta transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.Proc Natl Acad Sci USA 1985;82:4535–4538

    Article  PubMed  CAS  Google Scholar 

  23. Stern PH, Krieger NS, Nissenson RA,et al: Human transforming growth factor-alpha stimulates bone resorptionin vitro.J Clin Invest 1985;76:2016–2020

    PubMed  CAS  Google Scholar 

  24. Tashjian AH, Voelkel EF, Lloyd W,et al: Actions of growth factors on plasma calcium.J Clin Invest 1986;78:1405–1409

    PubMed  CAS  Google Scholar 

  25. Gutierrez GE, Mundy GR, Derynck R,et al: Inhibition of parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by transforming growth factor alpha and epidermal growth factor.J Biol Chem 1987;262:15845–15850

    PubMed  CAS  Google Scholar 

  26. Ibbotson KJ, D'Sousa SM, Ng KW,et al: Tumor-derived growth factor increases bone resorption in a tumor associated with the humoral hypercalcemia of malignancy.Science 1983;221:1292–1294

    Article  PubMed  CAS  Google Scholar 

  27. Rodan SB, Insogna KL, Vignery AMC,et al: Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.J Clin Invest 1983; 72:1511–1515

    PubMed  CAS  Google Scholar 

  28. Bertolini DR, Nedwin GE, Bringman TS,et al: Stimulation of bone resorption and inhibition of bone formationin vitro by human tumour necrosis factors.Nature 1986;319:516–518

    Article  PubMed  CAS  Google Scholar 

  29. Pfeilschifter J, Mundy GR, Roodman GD: Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cellsin vitro.J Bone Min Res 1989;4:113–118

    CAS  Google Scholar 

  30. Thomson BM, Mundy GR, Chambers TJ: Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.J Immunol 1987;138:775–779

    PubMed  CAS  Google Scholar 

  31. Tashjian Jr AJ, Voelkel EF, Lazzaro M,et al: Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism.Endocrinology 1987;120:2029–2036

    PubMed  CAS  Google Scholar 

  32. Johnson RA, Boyce BF, Mundy GR, Roodman GD: Tumors producing human TNF induce hypercalcemia and osteoclastic bone resorption in nude mice.Endocrinology 1989;124:1424–1427

    PubMed  CAS  Google Scholar 

  33. Sabatini M, Bonewald L, Chavez J, Mundy G: Production of GM-CSF by a human tumor associated with leukocytosis and hypercalcemia induces cytokine production by host cells [Abstract].J Bone Min Res (in press)

  34. Yoneda T, Alsina MM, Chavez JB, Bonewald L, Mundy GR: Hypercalcemia in a human tumor is due to tumor necrosis factor production by host immune cells [Abstract].J Bone Min Res (in press)

  35. Gowen M, Wood OD, Ihrie EJ,et al: An interleukin-1 like factor stimulates bone resorptionin vitro.Nature 1983;306:378–380

    Article  PubMed  CAS  Google Scholar 

  36. Heath JK, Saklatvala J, Meikle MC,et al: Pig interleukin-1 (catabolin) is a potent stimulator of bone resorptionin vitro.Calcif Tissue Int 1985;37:97

    Google Scholar 

  37. Gowen M, Mundy GR: Actions of recombinant interleukin-1, interleukin-2 and interferon gamma on bone resorptionin vitro.J Immunol 1986;136:2478–2482

    PubMed  CAS  Google Scholar 

  38. Dewhirst FE, Stashenko PP, Mole JE,et al: Purification of partial sequences of human osteoclast activating factor: identity with interleukin-1 beta.J Immunol 1985;135:2562–2568

    PubMed  CAS  Google Scholar 

  39. Sabatini M, Boyce B, Aufdemorte T,et al: Infusions of recombinant human interleukin-1 alpha and 1 beta cause hypercalcemia in normal mice.Proc Natl Acad Sci USA 1988;85:5235–5239

    Article  PubMed  CAS  Google Scholar 

  40. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR: Effects of interleukin-1 on bone turnover in normal mice.Endocrinology (in press)

  41. Boyce BF, Yates AJP, Mundy GR: Bolus injections of recombinant human interleukin-1 cause transient hypocalcemia in normal mice.Endocrinology, 1989 (submitted for publication)

  42. Sammon PJ, Wronski TJ, Flueck JA,et al: Humoral hypercalcemia of malignancy: evidence for interleukin-1 activity as a bone-resorbing factor released by human transitional-cell carcinoma cells. In: Cohn CV, Martin TJ, Meunier PJ (eds).Calcium Regulation and Bone Metabolism. Amsterdam: Elsevier Science, 1987;pp.383–396

    Google Scholar 

  43. Sato K, Fujii Y, Kasono K,et al: Parathyroid hormone-related protein and interleukin-1alpha synergistically stimulate bone resorptionin vitro and increase the serum calcium concentration in micein vivo.Endocrinology 1989;124:2172–2178

    Article  PubMed  CAS  Google Scholar 

  44. Dewhirst FE, Ago JM, Peros WJ, Stashenko P: Synergism between parathyroid hormone and interleukin-1 in stimulating bone resorption in organ culture.J Bone Min Res 1987;2:127

    Article  CAS  Google Scholar 

  45. Sabtini M, Garrett IR, Mundy GR: TNF potentiates the effects of interleukin-1 on bone resorptionin vitro.J Bone Min Res 1987;2(Suppl. 1):34

    Google Scholar 

  46. Gutierrez GE, Mundy GR, Derynck R,et al: Inhibition of parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by transforming growth factor alpha and epidermal growth factor.J Biol Chem 1987;262:15845–15850

    PubMed  CAS  Google Scholar 

  47. Bringhurst FR, Bierer BE, Godeau F,et al: Humoral hypercalcemia of malignancy: release of prostaglandin-stimulating bone-resorbing factorin vitro by human transitional-cell carcinoma cells.J Clin Invest 1986;77:456–464

    PubMed  CAS  Google Scholar 

  48. Shigeno C, Yamamoto I, Dokoh S,et al: Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.J Clin Endocrinol Metab 1985;61:761–768

    PubMed  CAS  Google Scholar 

  49. Tashjian AH, Voelkel EF, Levine L,et al: Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2: a new model for the hypercalcemia of cancer.J Exp Med 1972;136:1329–1343

    Article  PubMed  CAS  Google Scholar 

  50. Seyberth HW, Segre GV, Morgan JL,et al: Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.N Engl J Med 1975;293:1278–1283

    Article  PubMed  CAS  Google Scholar 

  51. Franklin RB, Tashjian AH: Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat.Endocrinology 1975;97:240–243

    PubMed  CAS  Google Scholar 

  52. Mundy GR, Wilkinson R, Heath DA: Comparative study of available medical therapy for hypercalcemia of malignancy.Am J Med 1983;74:421–432

    Article  PubMed  CAS  Google Scholar 

  53. Percival RC, Yates AJP, Gray RES,et al: Mechanisms of malignant hypercalcaemia in carcinoma of the breast.Br Med J 1985;291:776–779

    CAS  Google Scholar 

  54. Galasko CSB, Burn JI: Hypercalcemia in patients with advanced mammary cancer.Br Med J 1971;3:573–577

    Article  PubMed  CAS  Google Scholar 

  55. Eilon G, Mundy GR: Direct resorption of bone by human breast cancer cellsin vitro.Nature 1978;276:726–728

    Article  PubMed  CAS  Google Scholar 

  56. Boyde A, Macconachie E, Reid SA,et al: Scanning electron microscopy in bone pathology: review of methods and potential applications.Scanning Electron Microsc 1986;4:1537–1554

    Google Scholar 

  57. Saloman DS, Zweibel JA, Bano M,et al: Presence of transforming growth factors in human breast cancer cells.Cancer Res 1984;44:4069–4077

    Google Scholar 

  58. Perroteau I, Salomon D, DeBortoli M,et al: Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.Breast Cancer Res Treat 1986;7:201–210

    Article  PubMed  CAS  Google Scholar 

  59. Valentin A, Eilon G, Saez S,et al: Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.J Clin Invest 1985;75:726–731

    Google Scholar 

  60. Wo G, Bonewald LF, Oreffo ROC,et al: Evidence that lysosomal procathepsin D secreted by human breast cancer cells activates osteoclasts [Abstract].J Bone Min Res (in press)

  61. Mundy GR, Bertolini DR: Bone destruction and hypercalcemia in plasma cell myeloma. Semin Oncol 1986;13:291–299

    PubMed  CAS  Google Scholar 

  62. Mundy GR, Raisz LG, Copper RA,et al: Evidence for the secretion of an osteoclast-stimulating factor in myeloma.N Engl J Med 1974;291:1041–1046

    Article  PubMed  CAS  Google Scholar 

  63. Valentin-Opran A, Charhon SA, Meunier PJ,et al: Quantitative histology of myeloma-induced bone changes.Br J Haematol 1982;52:601–610

    PubMed  CAS  Google Scholar 

  64. Garrett IR, Durie BGM, Nedwin GE,et al: Production of the bone-resorbing cytokine lymphotoxin by cultured human myeloma cells.N Engl J Med 1987;317:526–532

    Article  PubMed  CAS  Google Scholar 

  65. Kurihara N, Suda T, Akiyama Y,et al: Interleukin-6 (IL-6) stimulates osteoclast formationin vitro by inducing IL-1 production [Abstract].Intl Soc Exper Hematol (in press)

  66. Breslau NA, McGuire JL, Zerwekh JE,et al: Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.Ann Intern Med 1984;100:1–7

    PubMed  CAS  Google Scholar 

  67. Fetchick DA, Bertolini DR, Sarin P,et al: Production of 1,25-dihydroxyvitamin D by human T cell lymphotropic virus-1 transformed lymphocytes.J Clin Invest 1986;78:592–596

    Article  PubMed  CAS  Google Scholar 

  68. Motokura T, Fukumoto S, Takahashi S,et al: Expression of parathyroid hormone-related protein in a human T cell lymphotropic virus 1-infected T cell line.Biochem Biophys Res Commun 1989;154:1182

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Endocrinology and Metabolism, University of Texas Health Science Center, 7703 Floyd Curl Drive, 78284, San Antonio, TX, USA

    Gregory R. Mundy

Authors
  1. Gregory R. Mundy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mundy, G.R. Incidence and pathophysiology of hypercalcemia. Calcif Tissue Int 46 (Suppl 1), S3–S10 (1990). https://doi.org/10.1007/BF02553287

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02553287

Keywords

Search

Navigation